Home/Filings/4/0001209191-22-016245
4//SEC Filing

Cassidy Meghan 4

Accession 0001209191-22-016245

CIK 0001755672other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:25 PM ET

Size

24.1 KB

Accession

0001209191-22-016245

Insider Transaction Report

Form 4
Period: 2022-03-02
Cassidy Meghan
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-02$26.76/sh+19,673$526,44975,190.914 total
  • Exercise/Conversion

    Common Stock

    2022-03-02$45.15/sh+9,132$412,310142,539.914 total
  • Exercise/Conversion

    Common Stock

    2022-03-02$34.68/sh+19,792$686,38794,982.914 total
  • Exercise/Conversion

    Common Stock

    2022-03-02$41.94/sh+8,624$361,691103,606.914 total
  • Exercise/Conversion

    Common Stock

    2022-03-02$31.22/sh+29,801$930,387133,407.914 total
  • Sale

    Common Stock

    2022-03-02$51.53/sh87,022$4,484,24455,517.914 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2022-03-0219,6730 total
    Exercise: $26.76Exp: 2026-02-02Common Stock (19,673 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2022-03-0219,7920 total
    Exercise: $34.68Exp: 2027-02-01Common Stock (19,792 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2022-03-028,6240 total
    Exercise: $41.94Exp: 2028-02-14Common Stock (8,624 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2022-03-0229,80114,901 total
    Exercise: $31.22Exp: 2030-02-20Common Stock (29,801 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2022-03-029,13218,266 total
    Exercise: $45.15Exp: 2031-02-25Common Stock (9,132 underlying)
Footnotes (4)
  • [F1]The price reported represents the weighted average price. These shares were sold in multiple transactions at prices ranging from $51.27 to $51.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]This option is fully vested and exercisable.
  • [F3]29,801 options are vested and exercisable. The remaining options will vest on February 21, 2023.
  • [F4]9,132 options are vested and exercisable. The remaining options will vest in two equal installments on February 26, 2023 and February 26, 2024.

Issuer

Corteva, Inc.

CIK 0001755672

Entity typeother

Related Parties

1
  • filerCIK 0001775175

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:25 PM ET
Size
24.1 KB